Results in Phase I Trial of OMP-54F28, a Wnt Inhibitor Targeting Cancer Stem Cells
May 31, 2014 · Comments Off
Phase 1 clinical trial results presented at ASCO 2014 pave way for cancer stem cell drug, OMP-54F28, in new clinical trials for pancreatic, ovarian, and hepatocellular cancers.
AACR News: Rigosertib Phase 1 results lead to disease-focused Phase 2 development
April 9, 2013 · Comments Off
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors. Intravenously rigosertib is already in phase 3 clinical trials for myelodysplastic syndrome and pancreatic cancer and oral rigosertib is being studied in a pair of Phase II trials in lower-risk transfusion dependent MDS patients. The drug candidate is being developed by Onconova Therapeutics, Inc., of Pennington, NJ.
That dude is tough as nails
May 30, 2012 · Comments Off
No sore throat should last a year and a half. Tim Elliott tried antibiotics and...
“It’s now a part of our family history”
April 23, 2012 · Comments Off
Blindsided by multiple cancer diagnoses in one year, family and friends decide to do something...
A five-year dispute over Gardasil, a vaccine that protects against human papillomavirus (HPV), just got...
NIH funds first cancer stem cell clinical trial at University of Colorado Cancer Center
September 19, 2011 · Comments Off
The National Institute of Health recently awarded University of Colorado Cancer Center investigator Antonio Jimeno...
Phase I trial of promising anti-cancer drug CUDC-101 opens with first patient treated at CU Cancer Center
August 18, 2011 · Comments Off
The University of Colorado Cancer Center has treated the first patient with a promising cancer-fighting...
The tale of the tongue
June 9, 2011 · Comments Off
Editor’s note: Mark Grogan is a head and neck cancer patient at the University of...
Caregiver shown all things possible
June 6, 2011 · Comments Off
By Myka Landry I am a caregiver to my husband, Pat. In 2009, Pat was...
NTRK1: a new oncogene and target in lung cancer
June 6, 2011
Wings of Hope to benefit pancreatic cancer research at CU Cancer Center
September 16, 2014 · No comments
A Teal Saturday: Gynecologic Cancer Symposium at CU
September 15, 2014 · No comments
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs... fb.me/3vrD9ACDf
"James Bond" stands up for ovarian cancer. fb.me/3NekZJ7ZG
Save the date! On October 30 enjoy an evening at the Wildlife Experience and listen to the amazing story of Eric... fb.me/1wuqrlnkS
What is the most adventurous thing you have ever done? For Eric Alexander guiding his blind friend up Mt. Everest... fb.me/6MSqUwEQy
Did you know? According to the American Lung Association lung cancer is the leading cancer killer in both men and... fb.me/2x4Bbj4Vc